Trypsin is a proteolytic enzyme which breaks down proteins. It is commonly used in medical applications such as dissociation of mammalian cells for viral production, culture initiation, tissue dissociation, and isolation of intracellular components from tissue cultures. The growing biopharmaceutical industry is fueling the demand for trypsin. Trypsin breaks down the proteins on the surface of cells allowing researchers to harvest individual cells for analysis.
The global Trypsin Market is estimated to be valued at US$ 46.72 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The strong growth of the trypsin market is attributed to the increasing demand from various medical applications. One of the key trends in the market is the growing adoption of single-use bioprocessing technologies in biopharmaceutical manufacturing. Single-use bioprocessing involves using disposable plastic bags, tubing, filters, and other components instead of conventional stainless steel equipment. This has significantly reduced production timelines and manufacturing costs. In the biopharmaceutical industry, single-use technologies use trypsin for cell harvesting applications. The biopharmaceutical manufacturers are shifting towards single-use technologies due to their advantages such as reduced capital investment and faster implementation of processes. Thus, the rising usage of single-use technologies in biopharmaceutical production is fueling the demand for trypsin, driving the market growth over the forecast period.
Segment Analysis
The global trypsin market is segmented by type, application, end user, and geography. By type, the pancreatic trypsin segment dominated the market and accounted for the largest revenue share in 2023. Pancreatic trypsin is majorly used in proteomic studies to aid protein extraction from various biological samples such as tissues and cells. It is also used in biochemical research as a digestive enzyme.
Key Takeaways
The global Trypsin Market Growth is estimated to be valued at US$ 46.72 Mn in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030.
Regional analysis: North America accounted for the maximum share of the global trypsin market in 2023. The presence of many established market players, advanced healthcare infrastructure, and rising research activities are fueling market growth in the region. Asia Pacific is anticipated to witness the fastest growth during the forecast period owing to rapidly growing healthcare industry, rising drug discovery activities, and increasing incidence of chronic diseases in the region.
Key players: The global trypsin market is consolidated in nature with a few dominating players accounting for major market share. Key players operating in the trypsin market are Pfizer, Inc., GlaxoSmithKline, Merck & Co., Inc., Johnson & Johnson. Pfizer, Inc. dominated the global market in 2023 owing to its strong brand presence and wide distribution network for proteolytic enzymes across major markets. The company offers various trypsin products such as ultrapure grade trypsin and sequencing grade modified trypsin.
For more insights, read- https://www.newsanalyticspro.com/trypsin-market-trends-size-and-share-analysis/
For more details on the report, Read- https://www.shayaricenter.com/natures-barcodes-biomarkers-illuminate-paths-to-wellness-and-scientific-breakthroughs
Comments
0 comment